Extra scrutiny is warranted to identify the underlying causes of chest pain in patients with nonobstructive coronary disease ...

Acute pulmonary embolism is a life-threatening condition because it places sudden strain on the right ventricle of the heart. In a multicenter case-control study, researchers in China found that ...

Acute pulmonary embolism (PE) is a life-threatening condition in which blood clots block vessels carrying deoxygenated blood ...

One month of dual antithrombotic therapy followed by direct oral anticoagulation alone may be as safe vs. 1 year of dual ...

Hypereosinophilic syndrome (HES) is a heterogeneous disorder characterised by persistent, abnormal eosinophil elevation in ...

New study shows a longer course of dual antithrombotic therapy may not be necessary for some patients with atrial ...

SAN FRANCISCO, CA—For patients with suspected myocardial infarction with nonobstructive coronary arteries (MINOCA), a strategy involving multifaceted exams to pinpoint the diagnosis and allow for ...

A randomized trial comparing an intensive to a standard diagnostic approach showed the suspected etiology, in cases of MI with nonobstructive coronary arteries, is often wrong.

Bristol Myers Squibb and Johnson & Johnson to discontinue phase 3 Librexia ACS trial of milvexian treat acute coronary syndrome: Princeton, New Jersey Monday, November 17, 2025, 1 ...

The Librexia clinical trial program includes two other Phase 3 trials, Librexia AF for patients with atrial fibrillation (AF) and Librexia STROKE for secondary stroke prevention (SSP). The IDMC ...

The landscape of coronary and pulmonary vascular medicine is undergoing a paradigm shift, fueled by breakthroughs in molecular biology, imaging, and ...

Kennedy said hormone therapy could "reduce the risks of cardiovascular disease and mortality by as much as 50%, Alzheimer's ...